Barrington Research Maintains Outperform on US Physical Therapy, Maintains $122 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an Outperform rating on US Physical Therapy (NYSE:USPH) with a price target of $122.
May 09, 2024 | 1:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research reaffirms an Outperform rating on US Physical Therapy with a $122 price target.
The reaffirmation of an Outperform rating and a $122 price target by Barrington Research suggests a positive outlook on US Physical Therapy's stock. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100